Search - tctmd.com

Displaying 41 - 60 of 100

Sort: Relevancy | Date

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Conference News TCT 2014

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

September 18, 2014

Presentation TCT 2014

A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS

Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Huay Cheem Tan

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

September 15, 2014

Presentation TCT 2014

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Anthony H. Gershlick

September 14, 2014

Presentation TCT 2014

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Renu Virmani

September 14, 2014

Presentation TCT 2014

Treatment Options for BMS and DES ISR: What Works Best?

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

Are Current DES Really Safer Than BMS?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Tullio Palmerini

September 14, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

Presentation TCT 2014

Case #2: A Patient Who Might Especially Benefit from the COBRA PzF-Shielded Stent

Presenter: Renu Virmani

September 13, 2014

Presentation TCT 2014

The Concept of the COBRA PzF-Shielded Stent

Presenter: Renu Virmani, Donald Cutlip

September 13, 2014

Presentation TCT 2014

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Fernando Alfonso

September 13, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

Presentation TCT 2013

DCB and BMS Interaction: A Critical Look at the Data

Presenter: Francesco Liistro

October 31, 2013

Advertisement

Novel Devices Present New Treatment Options for STEMI

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Keynote Address Focuses on Newer DES, Problematic Subgroups

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Treatment Options for BMS and DES ISR: What Works Best?

Are Current DES Really Safer Than BMS?

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

Case #2: A Patient Who Might Especially Benefit from the COBRA PzF-Shielded Stent

The Concept of the COBRA PzF-Shielded Stent

DCB in BMS vs DES ISR: Insights from the RIBS Trials

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

DCB and BMS Interaction: A Critical Look at the Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content